ArticleOncology research2026
CDK4 Mediates Cisplatin Resistance in Renal Cell Carcinoma (RCC) Cells by Regulating the ASH1L-CTR1 Axis.
Wenjian Zeng, Xianglong Li, Hao Cai, Qingyu Zhou, Shuangshuang Sun, Pingping Li, Sunlong Li, Zhi Chen
Abstract read
In one paragraphArticle in Oncology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Wenjian ZengDepartment of Oncology, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Xianglong LiDepartment of Chemotherapy, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Hao CaiDepartment of Oncology, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Qingyu ZhouDepartment of Chemotherapy, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Shuangshuang SunDepartment of Chemotherapy, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Pingping LiDepartment of Chemotherapy, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Sunlong LiDepartment of Oncology, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Zhi ChenDepartment of Chemotherapy, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Carcinoma, Renal CellCation Transport ProteinsCisplatinCyclin-Dependent Kinase 4DNA-Binding ProteinsDrug Resistance, NeoplasmHistone-Lysine N-MethyltransferaseKidney NeoplasmsTranscription FactorsAnimalsAntineoplastic AgentsCell Line, TumorCell ProliferationCopper Transporter 1FemaleGene Expression Regulation, NeoplasticAntineoplastic AgentsCation Transport ProteinsCDK4 protein, humanCisplatinCopper Transporter 1Cyclin-Dependent Kinase 4DNA-Binding ProteinsHistone-Lysine N-MethyltransferaseSLC31A1 protein, humanTranscription FactorsASH1-Like Histone Lysine Methyltransferase (ASH1L)cisplatin resistancecopper transporter 1 (CTR1)cyclin-dependent kinase 4 (CDK4)molecular mechanismRenal cell carcinoma
Identifiers
PMID42220427
PMCPMC13220077
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390